| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.606 | 0.007 | 0.606 | GABA C receptor rho-3 antagonist | 0.492 0.028 CID_24472 | ||
| 0.586 | 0.002 | 0.586 | Electron transport complex I inhibitor | |||
| 0.582 | 0.004 | 0.582 | Interleukin 1b antagonist | |||
| 0.486 | 0.009 | 0.486 | Anesthetic general | 0.425 0.014 CID_24472 | ||
| 0.5 | 0.027 | 0.5 | 5 Hydroxytryptamine release stimulant | 0.401 0.046 CID_24472 | ||
| 0.418 | 0.005 | 0.418 | Interleukin 1 antagonist | |||
| 0.407 | 0.009 | 0.407 | Alpha-N-acetylglucosaminidase inhibitor | 0.406 0.009 CID_24472 | ||
| 0.411 | 0.012 | 0.411 | 5 Hydroxytryptamine uptake stimulant | 0.3 0.044 CID_24472 | ||
| 0.436 | 0.071 | 0.436 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.436 0.071 CID_24472 | ||
| 0.366 | 0.004 | 0.366 | Ferrochelatase inhibitor | 0.204 0.022 CID_24472 | ||
| 0.312 | 0.004 | 0.312 | Bruton tyrosine kinase inhibitor | |||
| 0.311 | 0.009 | 0.311 | Succinate dehydrogenase inhibitor | 0.259 0.019 CID_24472 | ||
| 0.306 | 0.009 | 0.306 | GABA C receptor agonist | 0.235 0.015 CID_24472 | ||
| 0.29 | 0.003 | 0.29 | Fibroblast growth factor 4 antagonist | |||
| 0.312 | 0.028 | 0.327 | Tyrosine 3 hydroxylase inhibitor | 0.327 0.022 CID_24472 | CID_24472 | |
| 0.396 | 0.113 | 0.396 | Caspase 9 stimulant | 0.341 0.153 CID_24472 | ||
| 0.336 | 0.06 | 0.336 | Calcium channel activator | 0.301 0.09 CID_24472 | ||
| 0.306 | 0.036 | 0.306 | Peroxidase inhibitor | 0.279 0.041 CID_24472 | ||
| 0.261 | 0.006 | 0.261 | Triose-phosphate isomerase inhibitor | 0.175 0.014 CID_24472 | ||
| 0.253 | 0.011 | 0.253 | GABA C receptor rho-2 antagonist | 0.206 0.026 CID_24472 | ||
| 0.354 | 0.112 | 0.39 | 5 Hydroxytryptamine release inhibitor | 0.39 0.085 CID_24472 | CID_24472 | |
| 0.241 | 0.004 | 0.241 | Estrogen receptor alpha agonist | |||
| 0.301 | 0.066 | 0.301 | Aldehyde oxidase inhibitor | 0.3 0.066 CID_24472 | ||
| 0.241 | 0.007 | 0.241 | GABA C receptor antagonist | 0.187 0.016 CID_24472 | ||
| 0.288 | 0.055 | 0.288 | Superoxide dismutase inhibitor | 0.233 0.086 CID_24472 | ||
| 0.235 | 0.011 | 0.235 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.155 0.025 CID_24472 | ||
| 0.227 | 0.012 | 0.227 | Adenylate kinase inhibitor | 0.161 0.023 CID_24472 | ||
| 0.226 | 0.019 | 0.226 | Epidermal growth factor receptor kinase inhibitor | |||
| 0.21 | 0.011 | 0.21 | Porphobilinogen synthase inhibitor | 0.1 0.036 CID_24472 | ||
| 0.227 | 0.03 | 0.246 | 5 Hydroxytryptamine 3E antagonist | 0.246 0.018 CID_24472 | CID_24472 | |
| 0.205 | 0.012 | 0.205 | Estrogen antagonist | |||
| 0.234 | 0.045 | 0.254 | Nitric-oxide synthase stimulant | 0.254 0.03 CID_24472 | CID_24472 | |
| 0.193 | 0.005 | 0.193 | Estrogen receptor beta agonist | |||
| 0.195 | 0.009 | 0.195 | GABA C receptor rho-1 antagonist | 0.141 0.026 CID_24472 | ||
| 0.251 | 0.074 | 0.251 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.28 | 0.105 | 0.28 | Cholesterol antagonist | 0.237 0.135 CID_24472 | ||
| 0.233 | 0.061 | 0.233 | RNA-directed DNA polymerase inhibitor | 0.229 0.065 CID_24472 | ||
| 0.202 | 0.031 | 0.202 | Arachidonic acid antagonist | 0.195 0.038 CID_24472 | ||
| 0.189 | 0.02 | 0.207 | UDP-glucose 4-epimerase inhibitor | 0.207 0.017 CID_24472 | CID_24472 | |
| 0.181 | 0.013 | 0.181 | Phosphofructokinase-1 inhibitor | 0.148 0.018 CID_24472 | ||
| 0.187 | 0.02 | 0.187 | Adenylate cyclase stimulant | 0.151 0.06 CID_24472 | ||
| 0.172 | 0.007 | 0.172 | Biliverdin reductase inhibitor | 0.094 0.02 CID_24472 | ||
| 0.17 | 0.013 | 0.17 | Ca2+-transporting ATPase inhibitor | 0.17 0.013 CID_24472 | ||
| 0.165 | 0.015 | 0.165 | Electrolyte absorption antagonist | 0.111 0.044 CID_24472 | ||
| 0.163 | 0.015 | 0.179 | NADH dehydrogenase inhibitor | 0.179 0.013 CID_24472 | CID_24472 | |
| 0.229 | 0.084 | 0.229 | DNA synthesis inhibitor | 0.22 0.094 CID_24472 | ||
| 0.152 | 0.009 | 0.152 | Acyl-CoA dehydrogenase inhibitor | 0.109 0.014 CID_24472 | ||
| 0.154 | 0.015 | 0.154 | Glutamate dehydrogenase inhibitor | 0.102 0.029 CID_24472 | ||
| 0.139 | 0.013 | 0.141 | Carbamoyl phosphate synthetase inhibitor | 0.141 0.012 CID_24472 | CID_24472 | |
| 0.154 | 0.03 | 0.154 | Antineoplastic antibiotic | |||
| 0.133 | 0.01 | 0.133 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.097 0.015 CID_24472 | ||
| 0.136 | 0.012 | 0.136 | Estrogen agonist | |||
| 0.302 | 0.178 | 0.302 | MAP kinase 1 inhibitor | |||
| 0.146 | 0.026 | 0.15 | Creatine kinase inhibitor | 0.15 0.024 CID_24472 | CID_24472 | |
| 0.168 | 0.049 | 0.168 | CF transmembrane conductance regulator agonist | 0.147 0.081 CID_24472 | ||
| 0.135 | 0.016 | 0.135 | Glutamate decarboxylase inhibitor | 0.088 0.038 CID_24472 | ||
| 0.233 | 0.114 | 0.233 | Insulysin inhibitor | 0.188 0.176 CID_24472 | ||
| 0.141 | 0.026 | 0.141 | Epidermal growth factor antagonist | |||
| 0.127 | 0.016 | 0.127 | Phenylalanine 4-hydroxylase inhibitor | 0.08 0.038 CID_24472 | ||
| 0.136 | 0.026 | 0.136 | Anabolic | 0.114 0.045 CID_24472 | ||
| 0.254 | 0.152 | 0.254 | Histamine release inhibitor | 0.222 0.179 CID_24472 | ||
| 0.144 | 0.044 | 0.144 | Cystathionine beta-synthase inhibitor | 0.136 0.048 CID_24472 | ||
| 0.106 | 0.007 | 0.106 | Exportin-1 inhibitor | 0.085 0.019 CID_24472 | ||
| 0.103 | 0.004 | 0.103 | Kainate receptor 2 antagonist | |||
| 0.162 | 0.064 | 0.162 | Interferon gamma antagonist | 0.143 0.087 CID_24472 | ||
| 0.263 | 0.165 | 0.263 | Antibacterial | |||
| 0.17 | 0.073 | 0.17 | Phospholipase C inhibitor | 0.147 0.113 CID_24472 | ||
| 0.112 | 0.016 | 0.112 | Alcohol oxidase inhibitor | 0.1 0.018 CID_24472 | ||
| 0.129 | 0.036 | 0.129 | DOPA decarboxylase inhibitor | 0.122 0.043 CID_24472 | ||
| 0.133 | 0.043 | 0.133 | Photosensitizer | 0.099 0.091 CID_24472 | ||
| 0.112 | 0.023 | 0.112 | Glycine receptor antagonist | 0.096 0.036 CID_24472 | ||
| 0.093 | 0.008 | 0.093 | Kainate receptor antagonist | |||
| 0.1 | 0.017 | 0.1 | Vanilloid 4 agonist | 0.086 0.031 CID_24472 | ||
| 0.13 | 0.048 | 0.13 | 5 Hydroxytryptamine 3A agonist | 0.124 0.053 CID_24472 | ||
| 0.119 | 0.039 | 0.119 | Prolactin inhibitor | 0.095 0.06 CID_24472 | ||
| 0.096 | 0.016 | 0.096 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.078 0.042 CID_24472 | ||
| 0.143 | 0.064 | 0.143 | Heat shock protein 70 antagonist | |||
| 0.114 | 0.037 | 0.114 | Androgen antagonist | |||
| 0.114 | 0.037 | 0.114 | Lanosterol 14 alpha demethylase inhibitor | 0.105 0.048 CID_24472 | ||
| 0.102 | 0.026 | 0.102 | GABA aminotransferase inhibitor | |||
| 0.091 | 0.015 | 0.091 | Glutamate (mGluR6) antagonist | 0.088 0.017 CID_24472 | ||
| 0.083 | 0.007 | 0.083 | Adenylate cyclase 1 inhibitor | 0.05 0.026 CID_24472 | ||
| 0.097 | 0.023 | 0.098 | Glycine receptor agonist | 0.098 0.022 CID_24472 | CID_24472 | |
| 0.116 | 0.042 | 0.116 | HIV-1 integrase (Overall Integration) inhibitor | 0.089 0.066 CID_24472 | ||
| 0.08 | 0.009 | 0.09 | Glucose-6-phosphate isomerase inhibitor | 0.09 0.006 CID_24472 | CID_24472 | |
| 0.121 | 0.052 | 0.121 | Aminopeptidase B inhibitor | 0.108 0.06 CID_24472 | ||
| 0.082 | 0.013 | 0.082 | Aconitate hydratase inhibitor | 0.073 0.017 CID_24472 | ||
| 0.207 | 0.139 | 0.207 | Gastrin inhibitor | 0.191 0.163 CID_24472 | ||
| 0.149 | 0.083 | 0.149 | Melanin inhibitor | |||
| 0.123 | 0.057 | 0.133 | Microtubule formation inhibitor | 0.133 0.049 CID_24472 | CID_24472 | |
| 0.122 | 0.056 | 0.122 | TRPA1 agonist | |||
| 0.095 | 0.03 | 0.095 | Estrogen receptor alpha antagonist | |||
| 0.084 | 0.02 | 0.084 | Ornithine carbamoyltransferase inhibitor | 0.057 0.033 CID_24472 | ||
| 0.071 | 0.009 | 0.071 | Factor XIIIa inhibitor | |||
| 0.093 | 0.032 | 0.093 | Aminopeptidase I inhibitor | 0.083 0.039 CID_24472 | ||
| 0.138 | 0.076 | 0.153 | Mannose-6-phosphate isomerase inhibitor | 0.153 0.062 CID_24472 | CID_24472 | |
| 0.155 | 0.094 | 0.155 | 3C-like protease (Human coronavirus) inhibitor | 0.152 0.098 CID_24472 | ||
| 0.098 | 0.038 | 0.102 | Granulocyte macrophage colony stimulating factor agonist | 0.102 0.032 CID_24472 | CID_24472 | |
| 0.096 | 0.038 | 0.096 | CYP2A6 inhibitor | 0.067 0.063 CID_24472 | ||
| 0.169 | 0.112 | 0.179 | Neurotrophic factor enhancer | 0.179 0.099 CID_24472 | CID_24472 | |
| 0.093 | 0.036 | 0.093 | Janus tyrosine kinase 3 inhibitor | |||
| 0.127 | 0.072 | 0.127 | Vanilloid 1 agonist | |||
| 0.126 | 0.071 | 0.126 | Cyclooxygenase 3 inhibitor | 0.114 0.084 CID_24472 | ||
| 0.093 | 0.038 | 0.093 | Na+ K+ transporting ATPase inhibitor | 0.088 0.043 CID_24472 | ||
| 0.07 | 0.017 | 0.07 | Dihydroorotate oxidase inhibitor | |||
| 0.079 | 0.026 | 0.079 | Argininosuccinate synthase inhibitor | 0.073 0.028 CID_24472 | ||
| 0.085 | 0.033 | 0.085 | MAP kinase kinase 7 inhibitor | 0.074 0.067 CID_24472 | ||
| 0.06 | 0.007 | 0.06 | Kainate receptor agonist | 0.045 0.021 CID_24472 | ||
| 0.118 | 0.067 | 0.118 | Cholesterol synthesis inhibitor | |||
| 0.097 | 0.047 | 0.102 | Glutamate release inhibitor | 0.102 0.039 CID_24472 | CID_24472 | |
| 0.104 | 0.056 | 0.104 | Estrogen receptor beta antagonist | |||
| 0.062 | 0.014 | 0.062 | Dopamine beta hydroxylase inhibitor | 0.046 0.04 CID_24472 | ||
| 0.164 | 0.118 | 0.181 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.181 0.092 CID_24472 | CID_24472 | |
| 0.09 | 0.045 | 0.09 | D-Ala-D-Ala ligase inhibitor | 0.088 0.048 CID_24472 | ||
| 0.11 | 0.065 | 0.11 | Acetylcholine release stimulant | 0.1 0.088 CID_24472 | ||
| 0.079 | 0.035 | 0.079 | Phospholipase D inhibitor | 0.066 0.062 CID_24472 | ||
| 0.049 | 0.005 | 0.049 | Kainate receptor 1 antagonist | |||
| 0.087 | 0.043 | 0.087 | CC chemokine 5 receptor agonist | |||
| 0.133 | 0.091 | 0.133 | Pregnane X receptor agonist | |||
| 0.088 | 0.045 | 0.09 | Estrogen-related receptor beta agonist | 0.09 0.041 CID_24472 | CID_24472 | |
| 0.046 | 0.004 | 0.046 | S-adenosyl-L-homocysteine hydrolase inhibitor | |||
| 0.052 | 0.01 | 0.052 | Glutamate (mGluR8) agonist | 0.045 0.015 CID_24472 | ||
| 0.053 | 0.012 | 0.053 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.048 0.018 CID_24472 | ||
| 0.073 | 0.033 | 0.073 | 5 Hydroxytryptamine 3 agonist | |||
| 0.088 | 0.05 | 0.088 | Glutathione S-transferase inhibitor | |||
| 0.178 | 0.141 | 0.178 | Interleukin agonist | 0.168 0.151 CID_24472 | ||
| 0.053 | 0.016 | 0.053 | Dopamine D5 agonist | 0.045 0.022 CID_24472 | ||
| 0.068 | 0.032 | 0.068 | Dopamine uptake inhibitor | |||
| 0.05 | 0.013 | 0.05 | Fumarate hydratase inhibitor | 0.047 0.015 CID_24472 | ||
| 0.145 | 0.11 | 0.145 | ATPase inhibitor | |||
| 0.069 | 0.033 | 0.072 | Purinergic P2X1 antagonist | 0.072 0.03 CID_24472 | CID_24472 | |
| 0.105 | 0.071 | 0.105 | Mucolytic | 0.098 0.081 CID_24472 | ||
| 0.146 | 0.112 | 0.146 | Neurotensin receptor agonist | |||
| 0.037 | 0.004 | 0.037 | Factor XIII inhibitor | |||
| 0.072 | 0.039 | 0.072 | Glutamate (mGluR7) antagonist | 0.068 0.046 CID_24472 | ||
| 0.058 | 0.025 | 0.058 | Lysophosphatidic acid 3 receptor antagonist | 0.046 0.043 CID_24472 | ||
| 0.061 | 0.029 | 0.061 | Pregnane X receptor antagonist | 0.061 0.029 CID_24472 | ||
| 0.115 | 0.083 | 0.115 | Toll-Like receptor 2 antagonist | |||
| 0.111 | 0.081 | 0.111 | Aldehyde dehydrogenase inhibitor | |||
| 0.067 | 0.036 | 0.067 | Transcription factor RelA inhibitor | |||
| 0.035 | 0.005 | 0.035 | Vanilloid 2 agonist | 0.025 0.017 CID_24472 | ||
| 0.075 | 0.046 | 0.075 | Histidine decarboxylase inhibitor | 0.074 0.047 CID_24472 | ||
| 0.05 | 0.021 | 0.057 | Guanylate cyclase inhibitor | 0.057 0.014 CID_24472 | CID_24472 | |
| 0.113 | 0.085 | 0.118 | Cathepsin H inhibitor | 0.118 0.077 CID_24472 | CID_24472 | |
| 0.046 | 0.019 | 0.046 | Heme oxygenase inhibitor | 0.045 0.024 CID_24472 | ||
| 0.078 | 0.052 | 0.078 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.029 | 0.005 | 0.029 | NMDA receptor phencyclidine site antagonist | |||
| 0.056 | 0.032 | 0.067 | Alpha-mannosidase inhibitor | 0.067 0.019 CID_24472 | CID_24472 | |
| 0.035 | 0.011 | 0.035 | Purinergic P2Y15 antagonist | 0.034 0.012 CID_24472 | ||
| 0.06 | 0.037 | 0.06 | Ryanodine receptor antagonist | |||
| 0.064 | 0.043 | 0.064 | Calcium channel P-type blocker | 0.06 0.057 CID_24472 | ||
| 0.043 | 0.023 | 0.043 | Membrane dipeptidase inhibitor | |||
| 0.034 | 0.015 | 0.034 | Uridine phosphorylase inhibitor | 0.026 0.021 CID_24472 | ||
| 0.028 | 0.01 | 0.028 | Complement factor 1s inhibitor | |||
| 0.101 | 0.083 | 0.101 | Adenylate cyclase inhibitor | |||
| 0.118 | 0.102 | 0.118 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.053 | 0.037 | 0.053 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.048 0.046 CID_24472 | ||
| 0.05 | 0.035 | 0.05 | Potassium channel (Inward rectifier) activator | |||
| 0.029 | 0.014 | 0.029 | Nicotinic acid receptor 2 antagonist | |||
| 0.044 | 0.03 | 0.044 | Histamine H1 receptor agonist | |||
| 0.048 | 0.034 | 0.048 | Potassium channel (ATP-sensitive) activator | |||
| 0.035 | 0.022 | 0.035 | Adenosine uptake inhibitor | |||
| 0.059 | 0.045 | 0.059 | Neuraminidase inhibitor | |||
| 0.039 | 0.026 | 0.039 | Alpha 1d adrenoreceptor agonist | |||
| 0.092 | 0.079 | 0.095 | Carbonic anhydrase XV inhibitor | 0.095 0.074 CID_24472 | CID_24472 | |
| 0.127 | 0.115 | 0.127 | MAP kinase 3 inhibitor | |||
| 0.03 | 0.018 | 0.031 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.031 0.017 CID_24472 | CID_24472 | |
| 0.072 | 0.061 | 0.072 | GABA B receptor agonist | 0.071 0.066 CID_24472 | ||
| 0.038 | 0.027 | 0.038 | Vanilloid 3 antagonist | |||
| 0.02 | 0.01 | 0.02 | Methylmalonyl-CoA mutase inhibitor | 0.018 0.013 CID_24472 | ||
| 0.019 | 0.009 | 0.019 | Carbonic anhydrase X inhibitor | 0.019 0.009 CID_24472 | ||
| 0.019 | 0.009 | 0.019 | Carbonic anhydrase VIII inhibitor | 0.019 0.009 CID_24472 | ||
| 0.103 | 0.093 | 0.103 | Amylase inhibitor | |||
| 0.029 | 0.019 | 0.029 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.022 | 0.012 | 0.022 | Retinoid X beta receptor antagonist | |||
| 0.027 | 0.019 | 0.028 | Hedgehog signaling activator | 0.028 0.018 CID_24472 | CID_24472 | |
| 0.027 | 0.018 | 0.027 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.018 | 0.01 | 0.02 | Telomerase stimulant | 0.02 0.008 CID_24472 | CID_24472 | |
| 0.021 | 0.013 | 0.021 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.021 | 0.014 | 0.021 | Neuraminidase (Influenza B) inhibitor | |||
| 0.043 | 0.035 | 0.053 | Mannosidase inhibitor | 0.053 0.022 CID_24472 | CID_24472 | |
| 0.037 | 0.03 | 0.037 | 5 Hydroxytryptamine 2B agonist | |||
| 0.036 | 0.03 | 0.036 | Potassium channel Kv1.1 blocker | |||
| 0.031 | 0.025 | 0.031 | Glutamate (mGluR3) agonist | 0.03 0.029 CID_24472 | ||
| 0.037 | 0.031 | 0.037 | GABA uptake inhibitor | |||
| 0.044 | 0.038 | 0.044 | Dopamine transporter inhibitor | |||
| 0.025 | 0.019 | 0.025 | Thymidine phosphorylase inhibitor | |||
| 0.114 | 0.108 | 0.114 | Cell wall synthesis inhibitor | |||
| 0.09 | 0.085 | 0.104 | Glutamate (mGluR7) agonist | 0.104 0.052 CID_24472 | CID_24472 | |
| 0.028 | 0.023 | 0.028 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.051 | 0.046 | 0.051 | Epithelial sodium channel blocker | |||
| 0.035 | 0.03 | 0.035 | Diamine oxidase inhibitor | |||
| 0.042 | 0.038 | 0.042 | Adenosine deaminase inhibitor | |||
| 0.064 | 0.06 | 0.064 | MDM2 inhibitor | |||
| 0.021 | 0.018 | 0.021 | Prostaglandin F2 alpha agonist | |||
| 0.076 | 0.072 | 0.076 | Histamine N-methyltransferase inhibitor | |||
| 0.038 | 0.034 | 0.038 | Thymidine kinase inhibitor | |||
| 0.064 | 0.06 | 0.07 | Catalase inhibitor | 0.07 0.054 CID_24472 | CID_24472 | |
| 0.036 | 0.033 | 0.036 | Dihydropteroate synthase inhibitor | |||
| 0.023 | 0.02 | 0.023 | Glutamate (mGluR1) agonist | |||
| 0.076 | 0.072 | 0.076 | Ornithine decarboxylase inhibitor | |||
| 0.015 | 0.012 | 0.016 | Purinergic P2Y1 agonist | 0.016 0.01 CID_24472 | CID_24472 | |
| 0.039 | 0.036 | 0.039 | Histamine H2 receptor agonist | |||
| 0.049 | 0.047 | 0.049 | Nicotinic alpha3beta2 receptor antagonist | 0.049 0.046 CID_24472 | ||
| 0.045 | 0.043 | 0.045 | HCV NS3/NS4A protease inhibitor | |||
| 0.039 | 0.038 | 0.039 | Geranyltranstransferase inhibitor | |||
| 0.017 | 0.016 | 0.017 | Alpha 2b adrenoreceptor agonist | |||
| 0.031 | 0.03 | 0.031 | Phosphoglycerate kinase inhibitor | 0.031 0.03 CID_24472 | ||
| 0.019 | 0.018 | 0.019 | Imidazoline I1 receptor antagonist | |||
| 0.015 | 0.014 | 0.015 | Nicotinic alpha4 receptor agonist | |||
| 0.045 | 0.046 | 0.047 | Squalene epoxidase inhibitor | 0.047 0.041 CID_24472 | CID_24472 | |
| 0.011 | 0.012 | 0.015 | Lysophosphatidic acid receptor 3 agonist | 0.015 0.008 CID_24472 | CID_24472 | |
| 0.022 | 0.024 | 0.023 | Lysophosphatidic acid receptor 1 agonist | 0.023 0.021 CID_24472 | CID_24472 | |
| 0.02 | 0.024 | 0.021 | Isoleucine-tRNA ligase inhibitor | 0.021 0.019 CID_24472 | CID_24472 | |
| 0.025 | 0.032 | 0.027 | Estrogen-related receptor gamma antagonist | 0.027 0.024 CID_24472 | CID_24472 | |
| 0.012 | 0.025 | 0.016 | Cyclin T1 inhibitor | 0.016 0.015 CID_24472 | CID_24472 | |
| 0.052 | 0.066 | 0.069 | Acetylcholine M5 receptor agonist | 0.069 0.044 CID_24472 | CID_24472 | |
| 0.074 | 0.088 | 0.089 | mTOR complex 2 inhibitor | 0.089 0.049 CID_24472 | CID_24472 | |
| 0.072 | 0.1 | 0.088 | Sphingomyelinase inhibitor | 0.088 0.074 CID_24472 | CID_24472 | |
| 0.079 | 0.112 | 0.193 | Anesthetic local | 0.193 0.034 CID_24472 | CID_24472 | |
| 0.057 | 0.104 | 0.072 | Potassium channel (Tandem pore domain) blocker | 0.072 0.056 CID_24472 | CID_24472 | |
| 0.004 | 0.992 | 0.739 | Apoptosis agonist | 0.739 0.024 CID_24472 | CID_24472 | |
| 0.002 | 0.997 | 0.334 | Platelet adhesion inhibitor | 0.334 0.024 CID_24472 | CID_24472 | |
| 0.002 | 0.997 | 0.863 | Vasodilator | 0.863 0.002 CID_24472 | CID_24472 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |